Question: As of August 2016, what was the market capitalisation of the company that developed the drug Losmapimod?
Sentence (from "GlaxoSmithKline"): As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange.
Relevant evidence: Yes